The National Methadone Conference

American Association for the Treatment of Opioid Dependence
Washington, D.C. ~ April 13-16, 2003


Pre Conference Session 8:30 AM – 5:45 PM
April 12, 2003

Sharon Dow, MS
Joint Commission
Washington, DC
Joanne Page, MSW
Council On Accreditation
New York, NY
Walter Ginter
NAMA
Westport, CT
J. Thomas Payte, MD
Drug Dependence Associates
San Antonio, TX
Bettye Harrison, MSW, LISW
CARF Accreditation
Tucson, AZ
C. Todd Rosendale, MA
CSAT/Division of Pharmacologic Therapies
Rockville, MD
Herman Joseph, PhD
New York State Office of
Alcoholism and Substance Abuse Services
New York, NY
Joycelyn Sue Woods, MA
NAMA
New York, NY

NAMA would also like to thank our Faces of Advocacy: Alice Diorio, New England Alliance of Methadone Advocates; Robert Lubran, CSAT; Ira Marion, AECOM; Carmen Pearman, The MAG of Indiana; Valerie Robinson, DANYA; Rick Samson, FAVOR; Paul Samuels, Legal Action.

It is NAMA’s view that everyone who believes in methadone treatment is a potential methadone advocate. We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates (CMA) so that all energies directed toward the advancement of methadone treatment produce positive results.

This course fulfills the training requirement for certification as a Methadone Advocate. It is designed for non-clinicians, and involved eight hours of rigorous training. The course equips participants with the tools that they will need to succeed in the struggle to have methadone maintenance treatment universally accepted as the “gold standard” for addiction treatment.

With these goals in mind the course presentation is as follows:

  1. Addiction and Methadone – scientifically accurate yet in language understandable to the non-clinician.
  2. Regulations and Accreditation – explained by experts from CARF, COA and JCAHO who understand the systemic complexities.
  3. Faces of Advocacy – support for methadone treatment finds its source in both anticipated and unanticipated places in the community.
  4. The Certified Methadone Advocate (CMA) – the mechanism of certification and how it will professionalize those committed to advocacy.
  5. Methadone Stigma – a history of administrative and community prejudice directed at methadone patients, and analyses of possible solutions.

Candidates for certification must register with NAMA prior to the conference so that their Handbook may include information specific to their state.

Getting The Most From a Conference1
Jo. L. Sotheran, Ph.D.
National Alliance of Methadone Advocates

A short presentation on getting the most out of a conference, how to plan your time and networking skills. (powerpoint)

NAMA would like to thank Robert Kovacik— for donating his skills and materials to videotape the day’s training.

Photo Album of the CMA Training

Notes

1. This is a PowerPoint presentation.

Similar Posts

  • Denying Methadone Patients Medical Care

    Admin 04/18/2021

    The bias and misunderstandings about methadone as a medication often result in methadone patients being refused medical care (Umbricht-Schneiter, 1994; Zweben and Sorensen, 1988). Another common scenario is that their medication is used to coerce or manipulate methadone patients into medical treatment (Blansfield, 1992). In other areas of medicine such actions would be considered unethical…

  • |

    Quick Links

    Admin 11/28/2022

    Treatment Facility Locator Buprenorphine Physician Locator Center for Substance Abuse Treatment US government search engine to locate all forms of drug treatment. Substance Abuse Mental Health Services Administration (SAMHSA) US government search engine to locate physicians prescribing Buprenorphine. Code of Federal Regulations Federal Register, January 17, 2001   CRF 42 Part 8 in text and…

  • |

    OBOT Publications

    Admin 04/20/2023

    Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…

  • Links & Resources

    Admin 04/10/2021

    We Speak Methadone Join NAMA’s Bulletin Board and talk with other patients or just read what is happening around the world. SAMHSA Substance Abuse and Mental Health Services Administration. The federal agency that oversees mental health, substance abuse treatment and prevention agencies. CSAT Center for Substance Abuse Treatment. The federal agency under SAMHSA that oversees…

  • Richard Lane/Robert Holden Methadone Advocacy Award

    Admin 09/12/2022

    Richard Lane was a long-term heroin user who, upon release from prison in 1967 helped to start Man Alive, one of the Nation’s first methadone treatment programs. In 1974, he became Executive Director of the program and later served as Vice President of the American Methadone Treatment Association. He served on several committees and was…

  • |

    Patient Success Stories in Outpatient Medication-Assisted Treatment (MAT)

    Admin 03/10/2026

    Substance use disorders, particularly opioid dependence, remain a major public health challenge worldwide. One of the most effective and evidence-based approaches to treating opioid addiction is Medication-Assisted Treatment (MAT). MAT combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders comprehensively. Outpatient MAT programs allow patients to receive treatment while continuing their…